Allogene Therapeutics shares owned by GSA Capital Partners
Quarter-by-quarter ownership of Allogene Therapeutics (ALLO) shares owned by GSA Capital Partners
from 13F filings
Historical chart of GSA Capital Partners investment in Allogene Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Allogene Therapeutics held by GSA Capital Partners consolidated in one spreadsheet with up to 7 years of data
Download as csvQuarterly reported holdings in Allogene Therapeutics by GSA Capital Partners
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $227k | 183k | 1.24 |
| 2025-06-30 | $556k | 492k | 1.13 |
| 2025-03-31 | $706k | 484k | 1.46 |
| 2024-06-30 | $1.9M | 835k | 2.33 |
| 2023-12-31 | $66k | 21k | 3.22 |
| 2023-09-30 | $402k | 127k | 3.17 |
| 2022-12-31 | $1.6M | 251k | 6.29 |
| 2022-09-30 | $344k | 32k | 10.80 |
| 2022-03-31 | $1.4M | 149k | 9.11 |
| 2021-12-31 | $1.7M | 115k | 14.92 |
| 2021-06-30 | $364k | 14k | 26.09 |
| 2020-12-31 | $285k | 11k | 25.28 |
| 2019-12-31 | $276k | 11k | 25.98 |